• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型严重急性呼吸综合征冠状病毒2(SARS-CoV-2)变体的病死率差异。

Differences in case-fatality-rate of emerging SARS-CoV-2 variants.

作者信息

Liu Jing, Wei Haozhen, He Daihai

机构信息

Department of Applied Mathematics, Hong Kong Polytechnic University, Hong Kong, China.

Research Institute for Future Food, The Hong Kong Polytechnic University, Hong Kong, China.

出版信息

Public Health Pract (Oxf). 2023 Jun;5:100350. doi: 10.1016/j.puhip.2022.100350. Epub 2022 Dec 10.

DOI:10.1016/j.puhip.2022.100350
PMID:36532099
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9741492/
Abstract

OBJECTS

Variants of Severe-Acute-Respiratory-Syndrome Coronavirus-2 (SARS-CoV-2) has caused tremendous impact globally. It has been widely reported that the Omicron (B.1.1.529) variant is less deadly than the Delta (B.1.617.2) variant, presumably due to immunity from vaccination and previous infection. When measuring the severity of a variant, Case-Fatality-Rate (CFR) is often estimated. The purpose of this work is to calculate the change in CFR of different variants over time from a large number of countries/regions since the start of the pandemic in 2020.

STUDY DESIGN

A Cross-sectional study.

METHODS

We extend the comparison to all previous VOCs in 58 counties/regions. We use reported death divided by reported cases in 30-day sliding window with a two-week shift between reported death and reported cases.

RESULTS

The drop from Delta variant to Omicron variant is substantial and the difference between subvariants of Omicron is not evident.

CONCLUSION

We showed that the CFR dropped over time, presumably due to vaccine-induced immune and infection induced immune. Population age structure and prevalence of comorbidity influence CFR.

摘要

目的

严重急性呼吸综合征冠状病毒2(SARS-CoV-2)变体在全球造成了巨大影响。广泛报道称,奥密克戎(B.1.1.529)变体的致死性低于德尔塔(B.1.617.2)变体,推测这是由于疫苗接种和既往感染产生的免疫力。在衡量一个变体的严重程度时,通常会估算病死率(CFR)。这项工作的目的是计算自2020年大流行开始以来,来自大量国家/地区的不同变体的CFR随时间的变化。

研究设计

一项横断面研究。

方法

我们将比较范围扩大到58个县/地区的所有先前的变异株。我们使用报告死亡数除以30天滑动窗口内的报告病例数,报告死亡数和报告病例数之间有两周的时间偏移。

结果

从德尔塔变体到奥密克戎变体的下降幅度很大,奥密克戎亚变体之间的差异不明显。

结论

我们表明,CFR随时间下降,推测是由于疫苗诱导的免疫和感染诱导的免疫。人群年龄结构和合并症患病率会影响CFR。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b54/9772832/55185e71eebe/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b54/9772832/55185e71eebe/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b54/9772832/55185e71eebe/gr1.jpg

相似文献

1
Differences in case-fatality-rate of emerging SARS-CoV-2 variants.新型严重急性呼吸综合征冠状病毒2(SARS-CoV-2)变体的病死率差异。
Public Health Pract (Oxf). 2023 Jun;5:100350. doi: 10.1016/j.puhip.2022.100350. Epub 2022 Dec 10.
2
Differences in incidence and fatality of COVID-19 by SARS-CoV-2 Omicron variant versus Delta variant in relation to vaccine coverage: A world-wide review.奥密克戎变异株与德尔塔变异株相关的 COVID-19 发病率和病死率的差异与疫苗覆盖率有关:一项全球性综述。
J Med Virol. 2023 Jan;95(1):e28118. doi: 10.1002/jmv.28118. Epub 2022 Sep 20.
3
The case fatality rate of COVID-19 during the Delta and the Omicron epidemic phase: A meta-analysis.德尔塔和奥密克戎疫情阶段新冠病毒疾病的病死率:一项荟萃分析。
J Med Virol. 2023 Feb;95(2):e28522. doi: 10.1002/jmv.28522.
4
Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study.疫苗对 Alpha、Delta 或奥密克戎变异株引起的 SARS-CoV-2 感染或 COVID-19 住院的有效性:一项全国性丹麦队列研究。
PLoS Med. 2022 Sep 1;19(9):e1003992. doi: 10.1371/journal.pmed.1003992. eCollection 2022 Sep.
5
Disease severity and efficacy of homologous vaccination among patients infected with SARS-CoV-2 Delta or Omicron VOCs, compared to unvaccinated using main biomarkers.与未接种疫苗的患者相比,使用主要生物标志物比较感染 SARS-CoV-2 Delta 或 Omicron VOC 患者的疾病严重程度和同源疫苗接种效果。
J Med Virol. 2022 Dec;94(12):5867-5876. doi: 10.1002/jmv.28098. Epub 2022 Sep 9.
6
Vaccine effectiveness against SARS-CoV-2 reinfection during periods of Alpha, Delta, or Omicron dominance: A Danish nationwide study.疫苗对 Alpha、Delta 或奥密克戎变异株流行期间 SARS-CoV-2 再感染的有效性:一项丹麦全国性研究。
PLoS Med. 2022 Nov 22;19(11):e1004037. doi: 10.1371/journal.pmed.1004037. eCollection 2022 Nov.
7
Detection of SARS-CoV-2 in Saliva and Nasopharyngeal Swabs According to Viral Variants.根据病毒变异情况,在唾液和鼻咽拭子中检测 SARS-CoV-2。
Microbiol Spectr. 2022 Dec 21;10(6):e0213322. doi: 10.1128/spectrum.02133-22. Epub 2022 Nov 8.
8
Protection against symptomatic infection with delta (B.1.617.2) and omicron (B.1.1.529) BA.1 and BA.2 SARS-CoV-2 variants after previous infection and vaccination in adolescents in England, August, 2021-March, 2022: a national, observational, test-negative, case-control study.2021 年 8 月至 2022 年 3 月,英国青少年在先前感染和接种疫苗后对 delta(B.1.617.2)和 omicron(B.1.1.529)BA.1 和 BA.2 SARS-CoV-2 变异株的症状性感染的保护作用:一项全国性、观察性、基于检测的病例对照研究。
Lancet Infect Dis. 2023 Apr;23(4):435-444. doi: 10.1016/S1473-3099(22)00729-0. Epub 2022 Nov 24.
9
The identification and phylogenetic analysis of SARS-CoV-2 delta variants in Taiwan.台湾地区 SARS-CoV-2 德尔塔变异株的鉴定与系统进化分析。
Kaohsiung J Med Sci. 2023 Jun;39(6):624-636. doi: 10.1002/kjm2.12665. Epub 2023 Mar 23.
10
COVID-19 pandemic dynamics in India, the SARS-CoV-2 Delta variant, and implications for vaccination.印度的新冠疫情动态、严重急性呼吸综合征冠状病毒2(SARS-CoV-2)德尔塔变异株及其对疫苗接种的影响
medRxiv. 2021 Nov 22:2021.06.21.21259268. doi: 10.1101/2021.06.21.21259268.

引用本文的文献

1
Viral Infections in Special Populations: Key Findings and Perspectives from Special Issue.特殊人群中的病毒感染:特刊的关键发现与观点
Viruses. 2025 May 31;17(6):806. doi: 10.3390/v17060806.
2
COVID-19 burden of illness in people who are immunocompromised due to cancer: an expert opinion review.癌症导致免疫功能低下人群中 COVID-19 的疾病负担:专家意见综述
Oncologist. 2025 Jun 4;30(6). doi: 10.1093/oncolo/oyaf074.
3
Monitoring the Status of Multi-Wave Omicron Variant Outbreaks - 71 Countries, 2021-2023.监测多波奥密克戎变异株疫情的状况——71个国家,2021 - 2023年

本文引用的文献

1
COVID-19 pandemic dynamics in India, the SARS-CoV-2 Delta variant and implications for vaccination.印度的 COVID-19 大流行动态、SARS-CoV-2 德尔塔变异株及其对疫苗接种的影响。
J R Soc Interface. 2022 Jun;19(191):20210900. doi: 10.1098/rsif.2021.0900. Epub 2022 Jun 6.
2
Clinical severity of COVID-19 in patients admitted to hospital during the omicron wave in South Africa: a retrospective observational study.南非奥密克戎变异株流行期间住院患者的 COVID-19 临床严重程度:一项回顾性观察研究。
Lancet Glob Health. 2022 Jul;10(7):e961-e969. doi: 10.1016/S2214-109X(22)00114-0. Epub 2022 May 18.
3
Estimating disease severity of Omicron and Delta SARS-CoV-2 infections.
China CDC Wkly. 2024 Oct 11;6(41):1054-1058. doi: 10.46234/ccdcw2024.218.
4
An assessment of excess mortality during the COVID-19 pandemic, a retrospective post-mortem surveillance in 12 districts - Zambia, 2020-2022.评估 COVID-19 大流行期间的超额死亡率,2020-2022 年在赞比亚 12 个地区进行的回顾性死后监测。
BMC Public Health. 2024 Sep 27;24(1):2625. doi: 10.1186/s12889-024-20045-3.
5
The Clinical Severity of COVID-19 Variants of Concern: Retrospective Population-Based Analysis.关注的 COVID-19 变异株的临床严重程度:回顾性基于人群的分析。
JMIR Public Health Surveill. 2024 Aug 27;10:e45513. doi: 10.2196/45513.
6
Hybrid-Capture Target Enrichment in Human Pathogens: Identification, Evolution, Biosurveillance, and Genomic Epidemiology.人类病原体中的杂交捕获目标富集:鉴定、进化、生物监测和基因组流行病学
Pathogens. 2024 Mar 23;13(4):275. doi: 10.3390/pathogens13040275.
7
A Real-World Nationwide Study on COVID-19 Trend in Italy during the Autumn-Winter Season of 2020 (before Mass Vaccination) and 2021 (after Mass Vaccination) Integrated with a Retrospective Analysis of the Mortality Burden per Year.一项关于2020年秋冬季节(大规模接种疫苗前)和2021年(大规模接种疫苗后)意大利COVID-19趋势的全国性真实世界研究,并结合每年死亡负担的回顾性分析。
Microorganisms. 2024 Feb 21;12(3):435. doi: 10.3390/microorganisms12030435.
8
Mortality Trend of Severe COVID-19 in Under-Vaccinated Population Admitted to ICU in French Amazonia.法属亚马孙地区入住重症监护病房的疫苗接种不足人群中重症 COVID-19 的死亡率趋势
Trop Med Infect Dis. 2024 Jan 5;9(1):15. doi: 10.3390/tropicalmed9010015.
9
Sigma Receptor Ligands Prevent COVID Mortality In Vivo: Implications for Future Therapeutics.sigma 受体配体可预防 COVID 患者死亡:对未来治疗的启示。
Int J Mol Sci. 2023 Oct 29;24(21):15718. doi: 10.3390/ijms242115718.
10
Evaluation of COVID-19 vaccine effectiveness in different high-risk facility types during a period of Delta variant dominance in the Republic of Korea: a cross-sectional study.韩国德尔塔变异株主导时期不同高风险设施类型中新冠病毒疫苗有效性的评估:一项横断面研究
Osong Public Health Res Perspect. 2023 Oct;14(5):418-426. doi: 10.24171/j.phrp.2023.0188. Epub 2023 Oct 19.
估算奥密克戎和德尔塔 SARS-CoV-2 感染的疾病严重程度。
Nat Rev Immunol. 2022 May;22(5):267-269. doi: 10.1038/s41577-022-00720-5.
4
COVID-19 Incidence and Death Rates Among Unvaccinated and Fully Vaccinated Adults with and Without Booster Doses During Periods of Delta and Omicron Variant Emergence - 25 U.S. Jurisdictions, April 4-December 25, 2021.COVID-19 发病率和死亡率在有和没有加强针的未接种和完全接种成年人中,在德尔塔和奥密克戎变体出现期间-25 个美国司法管辖区,2021 年 4 月 4 日至 12 月 25 日。
MMWR Morb Mortal Wkly Rep. 2022 Jan 28;71(4):132-138. doi: 10.15585/mmwr.mm7104e2.
5
Characteristics and Outcomes of Hospitalized Patients in South Africa During the COVID-19 Omicron Wave Compared With Previous Waves.南非在 COVID-19 奥密克戎变异株流行期间住院患者的特征和结局与前几波相比。
JAMA. 2022 Feb 8;327(6):583-584. doi: 10.1001/jama.2021.24868.
6
Differences in the case fatality risks associated with SARS-CoV-2 Delta and non-Delta variants in relation to vaccine coverage: An early ecological study in the United Kingdom.与疫苗接种覆盖率相关的 SARS-CoV-2 德尔塔变体和非德尔塔变体的病例病死率风险差异:英国的一项早期生态学研究。
Infect Genet Evol. 2022 Jan;97:105162. doi: 10.1016/j.meegid.2021.105162. Epub 2021 Nov 27.
7
Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy.意大利新冠肺炎死亡患者的病死率及特征
JAMA. 2020 May 12;323(18):1775-1776. doi: 10.1001/jama.2020.4683.
8
Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State.华盛顿州 21 例 COVID-19 危重症患者的特征和结局。
JAMA. 2020 Apr 28;323(16):1612-1614. doi: 10.1001/jama.2020.4326.
9
The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2.严重急性呼吸综合征相关冠状病毒:将 2019-nCoV 进行分类并命名为 SARS-CoV-2。
Nat Microbiol. 2020 Apr;5(4):536-544. doi: 10.1038/s41564-020-0695-z. Epub 2020 Mar 2.